Additional insights on the modelling of the COVID-19 clinical progression using multi-state methodology

Autor: Cristina Vazquez Guillamet, Aaloke Mody, Andrew P. Michelson, Angella Sandra Namwase, Patrick G. Lyons, Pratik Sinha, William G. Powderly, Elvin Geng, Sean Yu, Keith F. Woeltje
Jazyk: angličtina
Rok vydání: 2021
Předmět:
Male
Epidemiology
medicine.medical_treatment
030204 cardiovascular system & hematology
law.invention
0302 clinical medicine
Interquartile range
law
longitudinal trajectory
030212 general & internal medicine
age-stratified mortality
multi-state analysis
Letter to the Editor
Multi state
Original Contribution
Middle Aged
Intensive care unit
Hospitals
Hospitalization
Intensive Care Units
Female
2019-20 coronavirus outbreak
medicine.medical_specialty
Coronavirus disease 2019 (COVID-19)
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
clinical course
MEDLINE
Computational biology
mechanical ventilation
03 medical and health sciences
Internal medicine
medicine
Humans
Decompensation
AcademicSubjects/MED00860
COVID-19 hospitalizations
Pandemics
Aged
Retrospective Studies
Mechanical ventilation
business.industry
SARS-CoV-2
Public health
COVID-19
Retrospective cohort study
Respiration
Artificial

Confidence interval
United States
ICU
business
Clinical progression
Zdroj: American Journal of Epidemiology
ISSN: 1476-6256
0002-9262
Popis: There are limited data on longitudinal outcomes for coronavirus disease 2019 (COVID-19) hospitalizations that account for transitions between clinical states over time. Using electronic health record data from a hospital network in the St. Louis, Missouri, region, we performed multistate analyses to examine longitudinal transitions and outcomes among hospitalized adults with laboratory-confirmed COVID-19 with respect to 15 mutually exclusive clinical states. Between March 15 and July 25, 2020, a total of 1,577 patients in the network were hospitalized with COVID-19 (49.9% male; median age, 63 years (interquartile range, 50–75); 58.8% Black). Overall, 34.1% (95% confidence interval (CI): 26.4, 41.8) had an intensive care unit admission and 12.3% (95% CI: 8.5, 16.1) received invasive mechanical ventilation (IMV). The risk of decompensation peaked immediately after admission; discharges peaked around days 3–5, and deaths plateaued between days 7 and 16. At 28 days, 12.6% (95% CI: 9.6, 15.6) of patients had died (4.2% (95% CI: 3.2, 5.2) had received IMV) and 80.8% (95% CI: 75.4, 86.1) had been discharged. Among those receiving IMV, 35.1% (95% CI: 28.2, 42.0) remained intubated after 14 days; after 28 days, 37.6% (95% CI: 30.4, 44.7) had died and only 37.7% (95% CI: 30.6, 44.7) had been discharged. Multistate methods offer granular characterizations of the clinical course of COVID-19 and provide essential information for guiding both clinical decision-making and public health planning.
Databáze: OpenAIRE